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Abstract A resurgence of interest in mitoehondriai physiology 
has recently developed as a result of new experimental data 
demonstrating that mitochondria function as important partici- 
pants in a diverse collection of novel intracellular signaling 
pathways. Cells depleted of mitochondrial DNA, or p0 cells, lack 
critical respiratory chain catalytic subunits that are encoded in 
the mitochondrial genome. Although p0 cells contain petit 
mitochondria, they cannot support normal oxidative phosphor- 
ylation and must survive and replicate using ATP derived solely 
from glycolysis. Without a functional electron transport chain, 
pO ceils cannot normally regulate redox potential and their 
mitochondria appear to be incapable of generating reactive 
oxygen species. Emerging evidence suggests that these signals 
are important components in a number of mitochondria-initiated 
signaling pathways. The present article focuses on how p0 cells 
have contributed to an understanding of the role that mitochon- 
dria play in distinct physiological pathways involved with 
apoptosis, glucose-induced insulin secretion, and oxygen sensing. 
© 1999 Federation of European Biochemical Societies. 
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1. Introduction 
The mitochondrion has long been referred to as the 'power- 
house' of the cell because of its ability to generate adenosine- 
5'-triphosphate (ATP) from adenosine-5'-diphosphate (ADP) 
and inorganic phosphate (Pi) via respiratory chain phosphor- 
ylation. However, the classical viewpoint hat mitochondria 
simply function as organelles responding to changes in ATP 
demand has recently given way to a more complex picture as 
data have emerged indicating that mitochondria also function 
as active signaling organelles in a number of important intra- 
cellular signaling pathways. A critical contribution to this 
growing understanding has come from an experimental p- 
proach using cells depleted of their mitochondrial DNA, or 
9 ° cells. Mammalian cell lines can be mutated into 9 ° cells by 
long-term exposure to ethidium bromide and are found to be 
dependent on uridine and pyruvate for growth [1,2]. The 
mammalian mitochondrial DNA encodes 13 polypeptides in- 
cluding critical catalytic subunits for complex I (NADH de- 
hydrogenase), complex III (bcl complex), complex IV (cyto- 
chrome c oxidase) and the FiF0 ATP synthase [3]. Thus, 9 ° 
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cells are not competent to carry out normal electron transport 
or ATP synthesis and must rely solely on ATP derived from 
anaerobic glycolysis for survival and growth. The fact that p0 
cells can survive without oxidative phosphorylation has al- 
lowed investigators to gain additional insight into the novel 
roles that mitochondria play in a number of signaling systems. 
For example, because they lack an electron transport system, 
9 o cells should be impaired in any signaling processes that are 
linked to mitochondrial redox potential or that involve the 
generation of mitochondrial superoxide via electron transfer 
to molecular 02. This article focuses on how 9 ° cells have 
helped to identify the role that mitochondria play in the intra- 
cellular signaling mechanisms involved in physiological proc- 
esses as diverse as apoptosis, glucose-induced insulin secretion 
and cellular oxygen sensing functions. 
2. Apoptosis 
Apoptosis is a morphologically distinct form of pro- 
grammed cell death that plays essential roles in development, 
tissue homeostasis and a wide variety of diseases including 
cancer, AIDS, stroke, myopathies and various neurodegener- 
ative disorders [4]. Apoptosis occurs after the activation of an 
intrinsic cell suicide program that is expressed in most mam- 
malian cells. Moreover, the key components of the apoptotic 
pathway have been conserved throughout evolution in species 
ranging from worms to man. The central components of the 
intrinsic apoptotic pathway appear to include caspases and 
mitochondria [5]. The caspases are a family of proteases 
that cleave proteins at specific aspartic acids. Caspases have 
been established as the apoptotic executioners esponsible for 
the morphological hallmarks of apoptosis including cell 
shrinkage, membrane blebbing, and chromatin degradation 
[6]. By contrast, the mitochondrial aspect of apoptosis has 
been more controversial [7]. Early evidence suggested that 
mitochondria might play a role in apoptosis because the 
anti-apoptotic proteins Bcl-2 and Bcl-xL appeared to localize 
to the mitochondria [8]. However, the observation that 9 ° cells 
could still undergo apoptosis in response to growth factor 
withdrawal seemed to suggest that normal mitochondria 
were not required for apoptosis [9]. A clearer picture of the 
mitochondrial involvement in the apoptotic process emerged 
when Wang and colleagues demonstrated that cytochrome c 
was one of the factors required for activation of the cell death 
protease, caspase-3, in a cell-free system [10]. Subsequent ex- 
periments demonstrated that intact cells were capable of re- 
leasing cytochrome c from mitochondria in response to di- 
verse apoptotic stimuli [11-13]. At about the same time, 
Kroemer and colleagues demonstrated that a 50-kDa protein 
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in the intermembrane space of mitochondria (termed apopto- 
sis inducing factor, or AIF) caused isolated nuclei to undergo 
apoptotic hanges including chromatin condensation and in- 
ternucleosomal DNA fragmentation in an in vitro system [14]. 
These studies also demonstrated that mitochondrial mem- 
brane potential can either hyperpolarize or hypopolarize fol- 
lowing exposure of the cells to pro-apoptotic stimuli. More- 
over, this change in mitochondrial membrane potential 
precedes the release of cytochrome c or AIF from mitochon- 
dria. The anti-apoptotic proteins Bcl-2 and Bcl-xL can pre- 
vent the change in mitochondrial membrane potential and 
thereby prevent he release of cytochrome c from mitochon- 
dria. Since neither cytochrome c nor AIF is encoded by mi- 
tochondrial DNA, it would be expected that p0 cells should 
still be able to undergo apoptosis following release of these 
factors to the cytosol. But the story became more confusing 
when it was demonstrated that 90 cells do not undergo apop- 
tosis in response to all stimuli that activate cell death in wild- 
type cells [15], which raises the question of why 90 cells are 
more resistant to some forms of apoptotic stimuli than others. 
To answer this question it is essential to recognize that 
changes in mitochondrial membrane potential likely precede 
cytochrome ~ release both in normal and in p0 cells. It is 
therefore imperative to understand how mitochondrial mem- 
brane potential is maintained in p0 cells lacking an electron 
transport system, and how various pro-apoptotic stimuli af- 
fect the maintenance of this potential. 
Normal cells generate mitochondrial membrane potential 
by pumping protons across the inner membrane via a process 
coupled to electron transfer along the electron transport 
chain. So how do p0 cells still maintain a mitochondrial trans- 
membrane potential when they lack key essential components 
of the electron transport chain? Interestingly, they maintain 
transmembrane potential by a different mechanism that can 
explain their different sensitivity to pro-apoptotic stimuli. Re- 
cently, Buchet and Godinot demonstrated that components of
the ATP synthase, along with a functional adenine nucleotide 
transporter (ANT), are required to maintain mitochondrial 
membrane potential in 9 ° cells [16]. Although p0 cells do 
not possess F0 subunits 6 and 8 of the ATP synthase ncoded 
by mitochondrial DNA, they do possess a functional FI-AT- 
Pase and a functional ANT. Within the mitochondrial matrix, 
ATP 4 hydrolysis is catalyzed by the FI subunit, yielding 
ADP 3 and Pi. The escape of ADP 3 from the matrix to 
the cytosol via the ANT is coupled to the uptake of ATP 4 
generated in the cytosol by anaerobic glycolysis. This concen- 
tration-driven exchange is electrogenic, and generates a suffi- 
cient mitochondrial membrane potential to prevent osmotic 
swelling of the matrix and subsequent cytochrome c release 
after rupture of the outer membrane. Thus, 9 ° cells maintain 
their membrane potential by virtue of ATP consumption i
their mitochondria. 
Based on Buchet and Godinot's observations, factors that 
inhibit the exchange of adenine nucleotides across the inner 
mitochondrial membrane should initiate apoptosis in p0 cells. 
For example, the ANT inhibitor bongkrekic acid and the F1- 
ATPase inhibitor aurovertin both induce growth arrest and 
membrane depolarization i  p0 cells. By contrast, 9° cells are 
insensitive to mitochondrial e ectron transport inhibitors uch 
as rotenone and antimycin [17] that are potent initiators of 
apoptosis in wild-type cells. In cell lines that are dependent on 
growth factors, withdrawal of interleukin-3 has been shown to 
inhibit the inner membrane xchange of adenine nucleotides 
in wild-type cells [18]. The loss in ADP supply to the mito- 
chondrial matrix results in a membrane hyperpolarization that 
causes osmotic rupture and cytochrome c release. Similarly, 
growth factor withdrawal in 9 ° cells should lead to an inhib- 
ition of adenine nucleotide xchange, thereby preventing the 
exchange of glycolytic ATP for mitochondrially generated 
ADP. The subsequent loss of mitochondrial membrane poten- 
tial would result in osmotic swelling and cytochrome c release. 
By contrast, apoptotic stimuli that affect other aspects of mi- 
tochondrial function appear not to induce apoptosis in 9 ° 
cells. For example, unlike wild-type cells, 9 ° cells are insensi- 
tive to tumor necrosis factor cz (TNFc 0 [15,19]. This observa- 
tion suggests that the mechanism of cell death after exposure 
to TNFc~ does not involve a primary disruption of the ANT. 
It is conceivable that TNFc~ could initiate a loss of mitochon- 
drial membrane potential in wild-type cells by disrupting elec- 
tron transport; previous investigations have also suggested 
that ceramide, a complex III electron transport inhibitor, 
may act as a signaling mediator in the mitochondrial dysfunc- 
tion induced by TNFc~ [19,20]. In any case, the sensitivity of 
9 ° cells to different apoptotic stimuli has yielded insight into 
the mechanisms of mitochondrial participation i the apopto- 
sis pathway in normal cell lines. 
3. Glucose-induced insulin secretion 
Glucose-stimulated insulin release from pancreatic beta cells 
involves a complex series of signaling pathways. Glucose, the 
main physiological secretagogue, results in an increase in the 
cytosolic ATP/ADP ratio as it is metabolized by the beta cell 
[21]. The rise in ATP/ADP ratio results in the closure of ATP- 
sensitive potassium channels (KATP) and subsequent depolari- 
zation of the plasma membrane. This leads to Ca 2+ influx 
through voltage-gated Ca 2+ channels and a rise in cytosolic 
Ca 2- concentration ([Ca2-]c) [22]. The increase in [Ca2+]c is 
the main trigger for exocytosis, the process by which insulin- 
containing secretory granules fuse with the plasma membrane 
[23]. A fundamental question underlying lucose-induced in-
sulin secretion relates to the source of the increased [ATP] in 
response to glucose uptake. Some investigators have argued 
that glycolytic, but not Krebs cycle metabolism of glucose is 
critically involved in this signaling process [24,25]. Studies 
have demonstrated that inhibitors of glycolysis uppress glu- 
cose-stimulated insulin secretion, whereas methyl pyruvate 
can generate a normal secretory response. Pancreatic islets 
exposed to exogenous pyruvate failed to respond in terms of 
a stimulation of insulin secretion, and did not demonstrate 
KATP channel closure even though islet cells can oxidize py- 
ruvate as effectively as glucose. Based on these observations it 
could be concluded that ATP derived from mitochondrial 
pyruvate metabolism does not substantially contribute to the 
regulation of KATP channels in response to a glucose chal- 
lenge. 
To determine the relative importance of mitochondrial ver- 
sus glycolytic ATP for the insulin secretion response to glu- 
cose, Soejima et al. tested whether 9 ° cells could respond to a 
glucose challenge [26]. If glycolytic stimulation were sufficient 
to augment [ATP] and to trigger KATe channel closure leading 
to insulin secretion, then p0 cells should augment insulin se- 
cretion in response to glucose challenge. By contrast, if ATP 
from the mitochondria s required then p0 cells should fail to 
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respond. Using p0 cells derived from a cultured mouse pan- 
creatic beta cell line MIN6, Soejima et al. showed that, unlike 
wild-type MIN6 cells, the MIN6 p0 cells failed to stimulate 
insulin secretion and failed to increase their [Ca2-]c in re- 
sponse to the glucose stimulus. The possible involvement of 
a nuclear genome-encoded factor in this response was ex- 
cluded by showing that the insulin secretion response could 
be restored in MIN6 p0 cells by re-populating them with for- 
eign mitochondria containing normal DNA. These results 
were corroborated by Kennedy et al. who demonstrated that 
p0 cells from the highly differentiated insulin-secreting cell line 
INS-I failed to increase [ATP] in response to glucose [27]. In 
addition, there was no effect of glucose on KArp yet depolar- 
ization of the plasma membrane with KC1 could still elicit 
insulin secretion. Also, Hayakawa et al. demonstrated that 
cells treated with ethidium bromide for 6 days, which presum- 
ably limited mitochondrial DNA replication, could no longer 
stimulate insulin secretion in response to elevated glucose, 
while the KATP channel blocker glibenclamide still did [28]. 
Collectively, these results indicated the importance of func- 
tional mitochondria in the insulin secretion response to glu- 
cose, but they did not resolve the paradox regarding the fail- 
ure of pyruvate to secrete insulin. Specifically, if increased 
[ATP] is required for the response, why does pyruvate fail 
to activate secretion even though it can be metabolized by 
islet cells'? Recently, Eto et al. suggested that the cytosolic 
pool of NADH may be an important participant in the signal- 
ing required for insulin secretion [29]. Those investigators 
found that the glucose-induced increases in ATP content 
and insulin secretion were abrogated if the glycerol phosphate 
and the malate-aspartate shuttles responsible for the transfer 
of cytosolic reducing equivalents into the mitochondria were 
inhibited. These results suggest that glycolysis-derived NADH 
may be an important source of mitochondrial energy produc- 
tion and metabolism in beta cells, and that mitochondria 
therefore function as critical signal transduction organelles 
in this response. 
4. Cellular oxygen sensing 
Oxygen is needed for the survival of virtually all mamma- 
lian cells due to its requirement for ATP synthesis. Accord- 
ingly, organisms have developed adaptive strategies at the 
organ level and at the cellular/molecular level to protect 
against he consequences of decreased oxygen availability (hy- 
poxia, Po2 < 40 Tort). Adaptive responses to hypoxia at the 
organismal level include pulmonary vasoconstriction (helping 
to maintain pulmonary gas exchange) and carotid body che- 
motransduction (helping to stimulate lung ventilation) [30]. 
Cellular and molecular adaptive responses to hypoxia include 
the activation of various transcription factors including hypo- 
xia inducible factor 1 (HIF-1) [31]. The HIF-1 complex is 
involved in the transcriptional activation of several genes 
that are responsive to the lack of oxygen, such as erythropoie- 
tin (EPO), vascular endothelial growth factor (VEGF) and 
glycolytic enzymes [32 34]. The HIF-I complex is composed 
of two b-HLH proteins: HIF-I[3 that is constitutively ex- 
pressed, and HIF-lc~, a protein whose rapid degradation by 
the proteasome pathway is inhibited during hypoxia [35]. 
Although much progress has been made in understanding 
the molecular mechanisms underlying the transcriptional cti- 
vation of glycolytic enzymes, EPO, and VEGF genes during 
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hypoxia, no consensus has evolved with respect o the identi- 
fication of the cellular 02 sensor esponsible for initiating the 
response to hypoxia. Early progress in understanding molec- 
ular mechanisms underlying mammalian oxygen sensing came 
from the observation that EPO mRNA can be induced under 
normoxic conditions in the human hepatoma Hep3B cell line 
by incubation with transition metals such as cobalt [36]. This 
led to the proposal that the sensor is a heme protein capable 
of interacting with 02. Subsequently, mechanisms including 
O2-sensitive potassium channels and NADPH oxidase have 
been proposed as possible oxygen sensors [37,38]. Since mito- 
chondria are the main site of oxygen consumption, they have 
long been considered as a possible site of 02 sensing. But 
studies using inhibitors of mitochondrial electron transport 
such as cyanide or azide have failed to elicit either an activa- 
tion during normoxia or an inhibition of HIF-1 activity dur- 
ing hypoxia, leading some to question the feasibility of their 
role in oxygen sensing [39]. 
We examined the role of mitochondria in the transcription- 
al response by assessing the ability of p0 cells to activate gene 
expression in response to hypoxia or cobalt [40]. Hypoxia and 
cobalt independently increased HIF-I  DNA binding and EPO 
mRNA levels in wild-type Hep3B cells. However, hypoxia 
failed to induce EPO mRNA expression or HIF-I  DNA bind- 
ing in p°-Hep3B cells. Yet surprisingly, p°-Hep3B cells main- 
tained their ability to activate HIF-1 DNA binding and EPO 
mRNA expression in response to cobalt chloride [40]. Collec- 
tively, these results indicate that a functional mitochondrial 
respiratory chain is required for the transcriptional response 
to hypoxia. Cobaltous ion, however, appears able to bypass 
this requirement, possibly by acting downstream of the mito- 
chondria. What aspect of mitochondrial function, i.e. ATP, 
calcium, reactive oxygen species, or mitochondrial membrane 
potential, is required for hypoxic activation? We focused on 
the possible role of reactive oxygen species (ROS) as signaling 
molecules required for the hypoxic stabilization of HIF-1 and 
subsequent induction of EPO mRNA. Previous reports had 
indicated that ROS can serve as signaling molecules by acti- 
vating transcription factors [41], although one might expect 
the intracellular generation of ROS to decrease when 02 
availability is lowered during hypoxia. Paradoxically, wild- 
type Hep3B cells increased their generation of ROS during 
hypoxia (1 2% 02), as evidenced by the increased rate of 
oxidation of 2,7-dichlorofluorescein (DCFH) dye [40]. This 
ROS generation requires electron transfer through mitochon- 
drial complex IIl, based on the observation that pharmaco- 
logical inhibitors of electron transport acting upstream of that 
site attenuated oxidation of the DCFH dye in wild-type cells, 
and that increased oxidation of DCFH dye was not detected 
in Hep3B p0 cells during hypoxia [40]. Interestingly, cobalt 
chloride increased the intracellular generation of ROS in 
both wild-type and p0 cells during normoxia, as evidenced 
by an increase in DCFH oxidation. The antioxidant com- 
pounds pyrrolidine dithiocarbamate and ebselen attenuated 
the ROS response and abolished the transcriptional ctivation 
of EPO and HIF-1 DNA binding during hypoxia in wild-type 
Hep3B cells. These antioxidants attenuated the ROS signal 
and abolished the transcriptional ctivation response to cobalt 
in both cell types [40]. These findings reveal that hypoxia 
activates gene transcription via a mitochondria-dependent sig- 
naling process involving increased ROS. By contrast, cobalt 
chloride appears to activate the same signaling system by 
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catalyzing the generation of ROS via a mechanism that does 
not require mitochondrial electron transport. 
5. Concluding remarks and perspectives 
The recent advances in diverse cell signaling pathways um- 
marized above have enhanced our understanding of thc roles 
that mitochondria play in the early intracellular events asso- 
ciated with apoptosis, glucose-induced insulin secretion, and 
02 sensing in diverse cell types. Although there is no question 
regarding the importance of mitochondria in maintaining the 
cellular bioenergetic state, these findings collectively under- 
score our growing realization that mitochondria lso function 
as initiators of intracellular signaling systems that are crit- 
ically important for cell survival and specialized cell functions. 
Because the bioenergetic functions of mitochondria re nor- 
mally essential for cell survival, it has been difficult or impos- 
sible in the past to uncover these additional roles using phar- 
macological studies because the acute inhibition of electron 
transport leads to rapid cell death. By creating a system 
that is not critically dependent on oxidative phosphorylation 
for survival, studies with p ° cells have contributed to our 
understanding of these novel signaling functions. 
References 
[1] King, M.P. and Attardi, G. (1989) Science 246, 500 503. 
[2] King, M.P. and Attardi, G. (1996) Methods Enzymol. 264, 304- 
313. 
[3] Anderson, S., Bankier, A.T., Barrell, B.G., de Bruijn, M.H., 
Coulson, A.R., Drouin, J., Eperon, I.C., Nierlich, D.P., Roe, 
B.A., Sanger, F., Schreier, P.H., Smith, A.J., Staden, R. and 
Young, 1.G. (1981) Nature 290, 457465. 
[4] Thompson, C.B. (1995) Science 267, 1456 1462. 
[5] Raft, M. (1998) Nature 396, 119 122. 
[6] Thornberry, N.A. and Lazebnik, Y. (1998) Science 281, 1312- 
1316. 
[7] Green, D.R. and Reed, J.C. (1998) Science 281, 1309-1312. 
[8] Hockenbery, D., Nunez, G., Milliman, C., Schreiber, R.D. and 
Korsmeyer, S.J. (1990) Nature 348, 334-336. 
[9] Jacobson, M.D., Burne, J.F., King, M.P., Miyashita, T., Reed, 
J.C. and Raft, M.C. (1993) Nature 361, 365 369. 
[10] Liu, X., Kim, C.N., Yang, J., Jemmerson, R. and Wang, X. 
(1996) Cell 86, 147 157. 
[11] Yang, J., Liu, X., Bhalla, K., Kim, C.N., Ibrado. A.M., Cai, J., 
Peng, T.I., Jones, D.P. and Wang, X. (1997) Science 275, 1129 
1132. 
[i2] Kluck, R.M., Bossy-Wetzel, E., Green, D.R. and Newmeyer, 
D.D. (1997) Science 275, 1132 1136. 
[13] Vander Heiden, M.G., Chandel, N.S., Williamson, E.K., Schu- 
macker, P.T. and Thompson, C.B. (1997) Cell 91, 627 637. 
[14] Susin, S.A., Zamzami, N., Castedo, M., Hirsch, T., Marchetti, 
N.S. Chandel, P.T. Schumacker/FEBS Letters 454 (1999) 173 176 
P., Macho, A., Daugas, E., Geuskens, M. and Kroemer, G. 
(1996) J. Exp. Med. 184, 1331 1341. 
[15] Higuchi, M., Aggarwal, B.B. and Yeh, E.T. (1997) J. Clin. lnvest. 
99, 1751-1758. 
[16] Buchet, K. and Godinot, C. (1998) J. Biol. Chem. 273, 22983 
22989. 
[17] Marchetti, P., Susin, S.A., Decaudin, D., Gamen, S., Castedo, 
M., Hirsch, T., Zamzami, N., Naval, J., Senik, A. and Kroemer, 
G. (1996) Cancer Res. 56, 2033 2038. 
[18] Vander Heiden, M.G., Chandel, N.S., Schumacker, P.T. and 
Thompson, C.B. (1999) Mol. Cell 3, 159 167. 
[19] Gudz, T.I., Tserng, K.Y. and Hoppel, C.L. (1997) J. Biol. Chem. 
272, 24154~4158. 
[20] Kolesnick, R. and Golde, D.W. (1994) Cell 77, 325 328. 
[21] Ashcroft, F.M., Proks, P., Smith, P.A., Ammala, C., Bokvist, K. 
and Rorsman, P. (1994) J. Cell Biochem. 55, 54 65. 
[22] Newgard, C.B. and McGarry, J.D. (1995) Annu. Rev. Biochem. 
64, 689 719. 
[23] Wollheim, C.B., Lang, J. and Regazzi, R. (1996) Diabetes Rev. 4, 
276 297. 
[24] Mertz, R.J., Worley, J.F., Spencer, B., Johnson, J.H. and Dukes, 
I.D. (1996) J. Biol. Chem: 271, 4838~-845. 
[25] Zawalich, W.S. and Zawalich, K.C. (1997) J. Biol. Chem. 272, 
3527 3531. 
[26] Soejima, A., Inoue, K., Takai, D., Kaneko, M., Ishihara, H., 
Oka, Y. and Hayashi, J.I. (1996) J. Biol. Chem. 271, 26194- 
26199. 
[27] Kennedy, E.D., Maechler, P. and Wollheim, C.B. (1998) Diabe- 
tes 47, 374-380. 
[28] Hayakawa, T., Noda, M., Yasuda, K., Yorifuji, H., Taniguchi, 
S., Miwa, I., Sakura, H., Terauchi, Y., Hayashi, J., Sharp, G.W., 
Kanazawa, Y., Akanuma, Y., Yazaki, y. and Kadowaki, T. 
(1998) J. Biol. Chem. 273, 20300 20307. 
[29] Eto, K., Tsubamoto, Y., Terauchi, Y., Sugiyama, T., Kishimoto, 
T., Takahashi, N., Yamauchi, N., Kubota, N., Murayama, S., 
Aizawa, T., Akanuma, Y., Aizawa, S., Kasai, H., Yazaki, Y. and 
Kadowaki, T. (1999) Science 283, 981 985. 
[30] Acker, H. (1994) Ann. NY Acad. Sci. 718, 3 10. 
[31] Semenza, G.L. (1998) Curr. Opin. Genet. Dev. 8, 588 594. 
[32] Levy, A.P., Levy, N.S., Wenger, S. and Goldberg, M.A. (1995) 
J. Biol. Chem. 270, 13333 13340. 
[33] Forsythe, J.A., Jiang, B.H., Iyer, N.V., Agani, F., Leung, S.W., 
Koos, R.D. and Semenza, G.L. (1996) Mol. Cell. Biol. 16, 4604- 
4613. 
[34] Semenza, G.L. and Wang, G.L. (1992) Mol. Cell. Biol. 12, 5447 
5454. 
[35] Wang, G.L., Jiang, B.H., Rue, E.A. and Semenza, G.L. (1995) 
Proc. Natl. Acad. Sci. USA 92, 5510-5514. 
[36] Goldberg, M.A., Dunning, S.P. and Bunn, H.F. (1988) Science 
242, 1412 1415. 
[37] Haddad, G.G. and Jiang, C. (1997) Annu. Rev. Physiol. 59, 23 
42. 
[38] Acker, H. (1994) Respir. Physiol. 95, 1-10. 
[39] Bunn, H.F. and Poyton, R.O. (1996) Physiol. Rev. 76, 839-885. 
[40] Chandel, N.S., Maltepe, E., Goldwasser, E., Mathieu, C.E., Si- 
mon, M.C. and Schumacker, P.T. (1998) Proc. Natl. Acad. Sci. 
USA 95, 11715 11720. 
[41] Finkel, T. (1998) Curr. Opin. Cell. Biol. 10, 248 253. 
